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Abstract
In Uganda, fisher folk have HIV prevalence rates, about four times higher than the national average, and are
often coinfected with Schistosoma mansoni. We hypothesized that innate immune responses and HIV-specific
Th1 immune responses might be downmodulated in HIV/S. mansoni-coinfected individuals compared with
HIV+/S. mansoni-negative individuals. We stimulated whole blood with innate receptor agonists and analyzed
supernatant cytokines by Luminex. We evaluated HIV-specific responses by intracellular cytokine staining for
IFN-c, IL-2, and TNF-a. We found that the plasma viral load and CD4 count were similar between the
HIV+SM+ and HIV+SM- individuals. In addition, the TNF-a response to the imidazoquinoline compound
CL097 and b-1, 3-glucan (curdlan), was significantly higher in HIV/S. mansoni-coinfected individuals com-
pared with HIV only-infected individuals. The frequency of HIV-specific IFN-c+IL-2–TNF-a- CD8 T cells and
IFN-c+IL-2–TNF-a+ CD4 T cells was significantly higher in HIV/S. mansoni-coinfected individuals compared
with HIV only-infected individuals. These findings do not support the hypothesis that S. mansoni down-
modulates innate or HIV-specific Th1 responses in HIV/S. mansoni-coinfected individuals.
Introduction
In Uganda, the national HIV prevalence fluctuates atabout 7%. However, high-risk groups such as the fishing
communities on the shores of Lake Victoria have preva-
lence about three to four times that of the national aver-
age.1 In addition, the Schistosoma mansoni prevalence in
the fishing communities living on the shores of Lake
Victoria is about 50%. Given the geographic overlap in
occurrence, HIV and S. mansoni coinfections occur in
these fishing communities.2,3
Mortality as a result of schistosomiasis is low, with pos-
sible subtle effects of schistosomiasis, such as the extent to
which schistosomiasis influences the host response to other
infections such as HIV, tuberculosis, and malaria, and the
response to vaccines.
The HIV (nonenvelope) specific antiviral T-cell immune
response is dominated by the secretion of IFN-c and TNF-a
(Th1 profile)4 and IL-17 (Th17 profile), whereas S. mansoni
infection in humans is predominantly characterized by se-
cretion of IL-4, IL-5, and IL-13 (Th2 profile) and IL-17
(Th17 profile) in the acute phase and a regulatory phenotype
(T regs) in the chronic phase.5 In coinfection of HIV and S.
mansoni, scanty data are available on the preferential de-
velopment, differentiation, and expansion of HIV-specific
Th1, Th2, or Th17 subpopulations.
The human innate immune system has developed pattern
recognition receptors, including nucleotide oligomerization
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domain (NOD)-like receptors (NLRs), Toll-like receptors
(TLRs), and retinoic acid-inducible gene-1 (RIG-I)-like re-
ceptors (RLRs), used to recognize pathogen-associated mo-
lecular patterns (PAMPs). HIV and its proteins have been
observed to have contrasting effects on TLR-related trig-
gering, for example, TLR 2 triggering is associated with in-
creased HIV transfer from dendritic cells (DCs) to CD4 T
cells, while TLR 4 triggering is associated with decreased
HIV transfer.6 HIV and its proteins also trigger TLR 7/8 and
TLR 7/9, resulting in the potent activation of DCs and the
release of copious amounts of IFN-a, IFN-b, and TNF-a,
promoting inflammation and immune activation, and shutting
down viral replication.7,8 However, gp120 disrupts TLR-9-
mediated plasmacytoid DC activation and NK activation, and
gp120 treatment suppresses TLR-9-induced secretion of
IFN-a and IFN-b.9
S. mansoni-derived molecules have been associated with
induction of cytokines with divergent influences on the T-cell
response profile at priming. In animal models, a Th1-type re-
sponse can be seen in the initial 4–5 weeks after infection,
switching to Th2 when egg production starts.10 Secretion of
IL-12p40 and IL-10 by thioglycollate-induced murine mac-
rophages stimulated with S. mansoni antigen is largely de-
pendent upon the presence of a functional TLR 4.11 However,
dextran-conjugated lacto-N-fucopentaose III, containing the
characteristic sugar moiety present in soluble egg antigen
(SEA), ligates TLR 4 and DC SIGN12 and skews immature
DCs to DC2, facilitating secretion of higher quantities of IL-4
and less IFN-a.13,14 Glycolipids from S. mansoniworms signal
through TLR 4, causing DC maturation with an inflammatory
bias and a Th1 profile in cocultured naı¨ve T cells.15 Lipids
from schistosome eggs are TLR 2 ligands and drive DCs to
produce IL-10.16 The combined ligation of TLR2 and TLR4
by different bacterial and helminth molecules induces distinct
gene expression signatures correlated with Th1 or Th2 polar-
ization in monocyte-derived human DCs.17 SEA has also been
shown to induce a Th2 bias in mice lacking TLR2, TLR4, or
MyD88.18 DC SIGN, a receptor on DCs, is ligated by both
gp120 and SEA, constituting an opportunity for competitive
interference.12 Both HIV and S. mansoni utilize TLRs in their
mechanism of establishing infection. This cross utilization
could affect the ability of cells from S. mansoni-infected in-
dividuals to mount an immune response to an incoming
pathogen such as HIV, and the triggering of TLR 2 or 4 by
S. mansoni, cercariae, egg, or worm antigen could affect HIV
transfer from DCs to CD4 T cells.
To investigate the immunological interaction between
HIV and S. mansoni, we have characterized cellular innate
responses to TLR agonists, and the adaptive immune re-
sponse to HIV antigen, in HIV+/S. mansoni-negative indi-
viduals and HIV+ individuals coinfected with S. mansoni.
We report that (a) TNF-a secretion in response to CL097
and curdlan stimulation is significantly higher in HIV/
S. mansoni-coinfected individuals compared with HIV+/
S. mansoni-negative individuals and (b) the frequency of
HIV-specific IFN-c+IL-2–TNF-a– CD8 T cells and IFN-
c+IL-2–TNF-a+CD4 T cells was significantly higher in HIV/
S. mansoni-coinfected individuals compared with HIV only-
infected individuals.
These findings do not support the hypothesis that S. man-
soni downmodulates innate or HIV-specific Th1 responses in
HIV/S. mansoni-coinfected individuals.
Materials and Methods
Ethics statement
The Institutional Ethics ReviewBoard of the Uganda Virus
Research Institute and the Uganda National Council of Sci-
ence and Technology approved the study. All subjects pro-
vided written informed consent.
Study groups
Fifty HIV-infected individuals were recalled 22–537 es-
timated days post-HIV infection and after exiting a larger 18-
month-long study investigating the HIV incidence and risk
factors for HIV acquisition in the Lambu, Kamuwunga, Na-
kiwogo, Kasenyi, and Nsazi fish landing sites on the shores
and islands of Lake Victoria.3,19
S. mansoni infection was determined by the standard Kato–
Katzmethod on three consecutive stool samples at recall visits.
S. mansoni infection status before HIV acquisition was de-
termined by circulating anodic antigen (CAA) assay20 in sera
samples collected at months 0, 6, 12, and 18 during the pre-
vious HIV incidence study. The HIV seroconversion date was
estimated as the mid-date between the date of last seronegative
test and the date of the first seropositive test.
Whole blood assay
Heparinized blood was diluted in a 1:1 ratio with Roswell
Park Memorial Institute (RPMI) 1640+HEPES (Sigma).
One hundred microliters of diluted blood and 100 ll of
each stimulus were added to a round-bottomed 96-well plate
and incubated at 5% CO2 37C for 24 h. The stimuli used
were lipopolysaccharide [LPS (100 ng/ml), InvivoGen];
PAM3CSKKKK [PAM (100 ng/ml), EMCMicrocollections,
Tu¨bingen, Germany]; synthetic lipoprotein, mycoplasma
type [FSL-1 (50 ng/ml), InvivoGen]; imidazoquinoline
compound [CL097 (1 lg/ml), InvivoGen]; CpG-ODN2006
[CpG (5 lg/ml), InvivoGen]; curdlan [Cur (100 lg/ml);
Wako Chemicals]; and phytohemagglutinin [PHA (10 lg/
ml), Sigma]. An equivalent volume of culture medium was
used as negative control. Two 75-ll aliquots of culture su-
pernatants were harvested and frozen.
A custom-made Bio-Rad Luminex kit (Cat. No.
L5007NCLYV) was used to measure IL-12p70, TNF-a, IFN-
c, IL-10, and IL-13 in culture supernatants following the
manufacturer’s instructions with modifications for testing
using half volumes. Briefly, 50 ll of thawed culture super-
natant was added to each well of a flat-bottomed plate con-
taining 0.5· coupled beads and incubated on a shaker at room
temperature (RT) for 30¢. After washing, 0.5· of detection
antibodies was added and incubated at RT for further 30¢. The
beads were washed, then 0.5· of streptavidin-PE was added
and incubated at RT for 10¢ and washed. Eighty microliters of
buffer was added and detection was done using a Bio-Plex
200 system with Bio-Plex manager, version 6.0. Cytokine
concentrations were determined using standard curves and
limits of quantitation calculated by the software according to
a four- or five-parameter logistic model. Since the upper limit
of quantitation varied between different assays, results above
the upper limit of quantitation were excluded. Background
responses (cultures with RPMI1640/HEPES) were subtracted
from the corresponding stimulated responses and any nega-
tive values were set to zero.
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Intracellular cytokine staining assay
Cryopreserved peripheral blood mononuclear cells (PBMC)
(1–2· 106) were thawed and rested for 6 h and stimulated
overnight in 1ml of complete medium [RPMI (Sigma), 10%
fetal bovine serum (PAA), 100 lg/ml penicillin, 100 units/ml
streptomycin (Lonza)] in the presence of Golgiplug (1ll/ml,
BD), anti-CD28 (0.5 lg/ml, BD), and 1 lg/ml of Gag po-
tential T-cell epitope (PTE) pools 1 and 2 peptides21. Sta-
phylococcus enterotoxin B (Sigma) stimulation (200 ng/ml)
was used as a positive control. Medium alone was used as a
negative control. At the end of the stimulation period, cells
were stained for 20¢ at 4C using Aqua LIVE/DEAD cell
stain (Invitrogen), fixed, and permeabilized (Cytofix/Cyto-
perm; BD) at RT for 20¢, and then stained at RT for 20¢ with
CD3-APC H7, CD4-PE-CF594, CD8-Pacific Blue, TNF-a-
FITC, IFN-c-APC, and IL-2-PE antibodies (all from BD).
Cellfix (BD) was added and 0.6–1 · 106 lymphocyte-gated
events were acquired on an LSRII SORP (BD). FlowJo version
9.7.4 (Treestar) was used in the analysis. To exclude doublets,
data on FSC-A and FSC-H were used. Aqua-positive cells
were also excluded (Supplementary Fig. S1; Supplementary
Data are available online at www.liebertpub.com/aid).
Only individuals classified as responders to each peptide
pool were compared. A peptide pool was considered to
stimulate a cytokine response if any of the IFN-cOR IL-2 OR
TNF-a responses were ‡0.05% after background subtraction.
For the polyfunctionality analysis, boolean-gated un-
stimulated responses were subtracted from corresponding
responses to stimuli and any resulting values below 0.01%
were set to 0%.
Statistical analyses
Analyses were done using GraphPad Prism 6.0. Student’s
t-test was used to compare means between the two groups.
The Holm–Sˇı´da´k method was used to correct for multiple
comparisons.
Results
Biomedical characteristics of study participants
Among the 34 participants whose innate immune response
was analyzed, 18 were HIV/S. mansoni coinfected. The mean
age of the HIV+SM+ individuals was 29.3 years and that of
HIV+SM- individuals was 29.4 years. The mean plasma viral
load among the HIV+SM+ coinfected individuals was 118,058
RNA copies per ml compared with 73,980 RNA copies per ml
for the HIV+SM- individuals. The mean CD4 count per mi-
croliter of blood among the HIV+SM+ individuals was 716
comparedwith651among theHIV+SM- individuals (Table 1).
Among the 38 participants whose adaptive immune re-
sponse was analyzed, 18 were HIV/S. mansoni coinfected.
The mean age of the HIV+SM+ individuals was 28.8 years
and that of HIV+SM- individuals was 28.4 years. The mean
plasma viral load among the HIV+SM+ coinfected individ-
uals was 115,989 RNA copies per ml compared with 123,058
RNA copies per ml for the HIV+SM- individuals. The mean
CD4 count per microliter of blood among the HIV+SM+
individuals was 748 compared with 734 among the HIV+SM-
individuals (Table 2). Participants were ART-naı¨ve and had
not received anthelmintic treatment in the previous 3 months.
Innate responses: association of S. mansoni coinfection
with higher TNF-a concentrations in whole blood cultures
from HIV+ individuals
We investigated innate cytokine responses in the context
of HIV/S. mansoni coinfections. Using CAA assays on
plasma collected at six monthly intervals during the HIV
incidence study, we could ascertain that S. mansoni infection
preceded the HIV infection in all coinfected cases; therefore,
Table 1. Biomedical Characteristics of Participants in the Innate Response Analysis
SM+ SM-
Female Male Female Male
No. of individuals (n) 6 12 9 7
Mean age in years
(range)
30 (21–39) 29 (23–41) 29 (20–45) 30 (24–37)
Mean CD4 count per ll
of blood (range)
559 (361–779) 795 (362–1,228) 514 (424–623) 826 (431–2,000)
Mean viral load copies
per ml (range)
73,294 (2,408–325,713) 140,440 (2,664–786,051) 94,735 (248–338,494) 47,294 (20–104,879)
Table 2. Biomedical Characteristics of Participants in the Adaptive Response Analysis
SM+ SM-
Female Male Female Male
No. of individuals (n) 3 15 11 9
Mean age in years (range) 28 (21–39) 29 (23–41) 27 (19–45) 30 (24–37)
Mean CD4 count per ll
of blood (range)
580 (361–779) 782 (362–1,228) 701 (436–1,115) 775 (417–2,000)
Mean viral load copies
per ml (range)
4,349 (2,408–5,957) 138,317 (2,664–786,051) 185,047 (248–830,432) 47,294 (20–104,879)
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HIVwould not have influenced the early course of S. mansoni
infection. Samples from 34 HIV-infected individuals, 18 of
whom were coinfected with S. mansoni, were evaluated in
these assays. We assayed culture supernatants from 34 indi-
viduals instead of 50 individuals because of experimental
failures and missing or used up samples.
The mean concentration of TNF-a in whole blood culture
supernatants following CL097 and curdlan stimulation of
whole blood cultures from HIV+SM+ individuals was sig-
nificantly higher compared with that of HIV+SM- individ-
uals [711 pg/ml vs. 316 pg/ml, p = .0017; 892 pg/ml vs.
484 pg/ml, p = .0012, respectively (Fig. 1A)]. In addition,
LPS stimulation was associated with somewhat stronger
TNF-a responses in HIV+SM+ individuals compared with
HIV+SM- individuals (Fig. 1A).
The remaining cytokine responses did not differ signifi-
cantly between HIV+SM+ and HIV+SM- (Fig. 1B–E).
The innate immune response was not stratified by sex
because a nonsignificant difference was observed when the
number of males to females was compared (data not shown).
Adaptive responses to HIV: association of S. mansoni
coinfection with higher frequency of Gag-specific
CD8 T cells producing IFN-c in HIV+ individuals
PBMCs obtained at the same visit as the whole blood for
innate responses were stimulated with Gag PTE pools 1 and
2 and we compared IFN-c, IL-2, and TNF-a production by
CD4 and CD8 T cells between HIV+SM+ and HIV+SM-
individuals. The mean frequency of CD8 T cells with an
IFN-c+ IL-2- TNF-a– profile in response to Gag PTE pool 1
A D
B E
C
FIG. 1. Cytokine response after agonist stimulation. TNF-a (A), IL-10 (B), IL-13 (C), IFN-c (D), and IL-12p70 (E)
concentrations (pg/ml) after 24-h whole blood stimulation with PAM, LPS, FSL-1, CL097, CpG, curdlan, and PHA. Only
significant p-values are indicated in the figure. HIV+SM+ n = 18 and HIV+SM- n = 16 for all stimuli except CpG where
n = 17 for the HIV+SM+. Student’s t-test and the Holm–Sˇı´da´k correction for multiple comparisons were used to compare the
response to each stimuli between HIV/S. mansoni coinfected (SM+) and HIV+SM- infected only. Only significant p-values
are shown.
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(0.7% vs. 0.40%, p < .0060) and Gag PTE pool 2 (0.43%
vs. 0.25%, p < 4.3 · 10-6) was significantly higher in HIV+
SM+ individuals compared with HIV+SM- individuals
(Fig. 2C, D).
The mean frequency of CD4 T cells with an IFN-c+ IL-2-
TNF-a+ profile in response toGagPTEpool 1 (mean 0.05%vs.
0.02%,p< .0071) andGag PTEpool 2 (mean 0.03%vs. 0.01%,
p< .0015) was also significantly higher in HIV+SM+ individ-
uals compared with HIV+SM- individuals (Fig. 2A, B).
The dominant cytokine response combinations in the CD8
subset were IFN-c+ IL-2- TNF-a- and IFN-c+ IL-2- TNF-
a+ (Fig. 2C, D) and IFN-c+ IL-2- TNF-a+ for the CD4 subset
(Fig. 2A, B). The CD4 subset had a more even distribution of
cells producing 1 or 2 cytokine combinations in both
HIV+SM+ and HIV+SM-, but their frequency was lower
than among CD8 T cells (Fig. 2A, B). Few cells were IFN-c+
IL-2+ TNF-a+.
Since we had a significant excess of males in the
S. mansoni-coinfected participants, we stratified the analysis by
sex. The mean frequency of CD4 T cells expressing IFN-c+ IL-
2- TNF-a+ was higher among the HIV+SM+ males compared
with HIV+SM-males (mean= 0.035% vs. 0.0033%; p= .0005)
for Gag PTE pool 2. The frequency of CD8 T cells expressing
IFN-c+ IL-2- TNF-a- was higher among the HIV+SM+males
compared with HIV+SM- males (mean=0.43% vs. 0.15%;
p=4.2·10-8) for cells stimulated with Gag PTE pool 2.
No statistical significant difference was observed between
the HIV+SM+ and HIV+SM- females (data not shown).
Discussion
We investigated the innate and adaptive cytokine and che-
mokine profiles in the context of HIV/S. mansoni coinfection,
where S. mansoni infectionwas acquired beforeHIV infection.
Effects on innate immunity
Innate immune cells from HIV+SM+ individuals had a
higher secretion of TNF-a in response to CL097 and curdlan
stimulations compared with HIV+SM- individuals. We did
not observe any significant downregulation of cytokine in-
nate responses in HIV+SM+ individuals compared with
HIV+SM- individuals.
A B
C D
FIG. 2. Functional profile of HIV-specific CD4 and CD8 T-cell responses in HIV/S. mansoni coinfected and HIV only
infection. Analysis of the functional profile of secretion of IFN-c, IL-2, and TNF-a in response to Gag PTE pool-1 (A), (C),
SM + n = 18, SM- n = 17, and Gag PTE pool 2 (B), (D) SM+ n = 17, SM- n = 18. All possible combinations of positive
responses are shown on the x-axis, whereas the frequency of cytokine-producing CD4 or CD8 T cells is shown on the y-axis.
Student’s t-test and the Holm–Sˇı´da´k correction for multiple comparisons were used to compare the response to each PTE
pool between HIV/S. mansoni-coinfected (SM+) and HIV+SM- -infected individuals. Only significant p values are shown.
PTE, potential T-cell epitope.
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TNF-a is a proinflammatory cytokine, which has been
connected with the hepatic granuloma response to S. mansoni
eggs. However, we did not find significant differences in ex
vivo cytokine production in unstimulated whole blood from
HIV+SM+ and HIV+SM- individuals. Instead, we found
enhanced responsiveness to imidazoquinoline compound
CL097 and curdlan in HIV+SM+ individuals compared with
HIV+SM- individuals, suggesting a change in the functional
profile of antigen presentation, which could result in increased
T-cell responses to antigens presented by TLR7/8- and dectin-
expressing APCs that encountered the corresponding TLR li-
gand in vivo. This view is supported by the report that APCs
treated with imidazoquinoline ligands of TLR7 and TLR9 or
CpG can enhance TNF-a and IFN-c T-cell responses to HIV
peptides in vitro22 and by our own findings of a bias toward
IFN-c and TNF-a responses in ex vivoCD8 T cells specific for
HIV Gag.
Stimulation with particulate b-1,3-glucan (curdlan) induced
the most enhanced differences in TNF-a response between
HIV+SM+ and HIV+SM- individuals. This suggests that
S. mansoni might be interfering with the b-glucan->dectin-1-
>Raf-1 signaling pathway, which produces extensive epige-
netic reprogramming in the differentiation of monocytes
to macrophages23 and trained immunity, a form of innate
memory.24
The identity of the S. mansoni products that might be in-
volved is unclear. Blocking experiments with low-molecular-
weight soluble glucan laminarin suggest that dectin-1 is not
involved in SEA binding25; however, the requirement for a
particle to activate dectin-1 responses26 might be fulfilled by
ligands immobilized on the schistosome egg surface.
The presence of the proinflammatory cytokine, TNF-a, is
likely sensed directly by the worms that encode a TNF-a
receptor,27 and egg production is delayed in T-cell-deficient
SCID mice, which, however, retain innate sources of TNF-a
that could compensate the missing output from T cells.28
IFN-c was associated with protection against liver fibrosis
in human infection with S. mansoni,29 and both IFN-c and
T-bet have been identified as factors restraining severe
granuloma pathology associated with IL-17 responses in
mouse models of S. mansoni infection.30,31 Although we
could not discern differences between HIV+SM+ versus
HIV+SM- individuals in the IFN-c response to innate stim-
uli, the frequency of IFN-c+ CD8 T cells and IFN-c+TNF-a+
CD4 T cells in response to HIV was significantly enhanced in
coinfected individuals.
IL-10 has been suggested as a mechanism through which
S. mansoni induces downmodulation of Th1 immune re-
sponses.32,33 In this study, we observed a nonsignificant trend
toward higher IL-10 production in whole blood cultures from
HIV+SM+ versus HIV+SM-; however, no significant
downmodulation of IFN-c or TNF-a or IL-2 production by
either CD4 or CD8 T cell was observed in HIV+SM+ versus
HIV+SM- individuals.
Effects on adaptive T-cell responses
CD4 T cells play a major role in the pathogenesis of HIV
and S. mansoni. HIV infects and replicates in CD4 T cells,
resulting in death of the infected cells and immunodeficiency,
whereas in schistosomiasis, CD4 T cells play a role in host
resistance to infection34 and excretion of parasite eggs.35 In
this study, we report that the frequency of HIV-specific IFN-
c+ IL-2- TNF-a+ CD4 T cells and IFN-c+ IL-2- TNF-a-
CD8 T cells in response to Gag PTE pools 1 and 2 was
significantly higher in the HIV+SM+ individuals compared
with HIV+SM- individuals, suggesting that S. mansoni in-
fection enhanced HIV-specific Th1 and CD8 T-cell re-
sponses. Among HIV+SM+ males only, the frequency of
IFN-c+IL-2-TNF-a+ CD4 T cells and IFN-c+IL-2- TNF-a-
CD8 T cells in response to Gag PTE pool 2 was significantly
enhanced in the HIV+SM+ individuals compared with
HIV+SM- individuals.
In the context of S. mansoni infection, the higher frequency
of males with S. mansoni infection compared with females is
likely due to exposure while fishing, which is largely done by
males in the community studied. In the analysis stratified by
sex, we did not retain statistically significant differences in
acquired responses to HIV in the females. This could be due
to biological differences related to sex or could simply reflect
the small number of females with S. mansoni infection (3
SM+ vs. 10 SM-).
In a coinfection with HIV and S. mansoni, pathogens
characterized by different cytokine secretion profiles, it is
not clear whether the interaction is more detrimental or
beneficial for the host when compared with each infection
on its own. Chronic inflammation measured by the presence
of cytokines such as TNF-a, IFN-c, and IL-1b has been
shown to exacerbate HIV pathogenesis,36 and S. mansoni
might increase HIV disease progression through enhanced
immune activation.
Unlike pathologies such as multiple sclerosis where
S. mansoni SEA seems to downregulate autoimmune in-
flammation mediated through IFN-c, TNF-a, and IL-17 by
inducing suppressor of cytokine signaling 3 (SOCS3)37,38 or
coinfection with HTLV-I, where the Th1 type response to the
virus is curbed,39 the overall profile that emerges from the
innate and acquired responses in HIV/S. mansoni-coinfected
individuals is more proinflammatory than in single HIV in-
fection, although some regulatory effect might be exerted by
IL-10, which showed a trend for increased responsiveness to
various TLR ligands together with TNF-a and IFN-c. Since
individuals in the present study were infected with HIV for an
average of 405 days (105–625 days), we cannot exclude the
possibility that downmodulatory effects of S. mansoni on
HIV immune responses might become detectable over a
longer time.
Previous studies have suggested a detrimental effect of
S. mansoni coinfection on the disease progression in HIV-
infected individuals; however, there is no consensus on the
benefits of anthelmintic treatment in coinfections with
HIV.40,41 Praziquantel treatment was followed by changes in
the cytokine response to S. mansoni toward a Th2 profile, but
less so in HIV-coinfected individuals,42 and toward a more
proinflammatory phenotype in single infections with S.
haematobium.43 We are currently conducting a larger study
to discern the effect of annual versus three-monthly prazi-
quantel treatment in HIV+SM+ -coinfected individuals on
HIV viral load. Interestingly, S. mansoni does not appear to
have an effect on HIV acquisition in Ugandan fisher folk,2,3
unlike in Tanzanian women.44
These conflicting reports reflect the complexity of con-
current responses to multiple antigens and the probable active
role of live worms in immune regulation. These results
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suggest that any detrimental effect of coinfection is more
likely due to enhanced HIV disease progression facilitated by
an inflammatory environment than to downregulation of anti-
HIV responses.
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